Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GBS Inc. stock logo
GBS
GBS
$1.58
+1.9%
$1.75
$0.36
$2.89
$23.53M1.32955,325 shs92,576 shs
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
$3.12
-1.3%
$3.05
$9.41
$13.80
$34.98M0.09205,918 shs105,841 shs
INVO Fertility, Inc stock logo
IVF
INVO Fertility
$1.84
+1.1%
$3.31
$1.61
$51.12
$1.31M1.993.62 million shs887,806 shs
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$0.81
+0.9%
$0.77
$0.29
$0.98
$22.22M0.8420,146 shs3,616 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GBS Inc. stock logo
GBS
GBS
-1.86%-16.84%-8.14%+16.18%+18.80%
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
0.00%-3.11%+12.64%+13.87%-57.72%
INVO Fertility, Inc stock logo
IVF
INVO Fertility
+1.10%-17.86%-27.38%-65.93%-94.32%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
+4.20%+0.88%+3.79%+27.89%+26.09%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
GBS Inc. stock logo
GBS
GBS
N/AN/AN/AN/AN/AN/AN/AN/A
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
N/AN/AN/AN/AN/AN/AN/AN/A
INVO Fertility, Inc stock logo
IVF
INVO Fertility
N/AN/AN/AN/AN/AN/AN/AN/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GBS Inc. stock logo
GBS
GBS
0.00
N/AN/AN/A
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
0.00
N/AN/AN/A
INVO Fertility, Inc stock logo
IVF
INVO Fertility
0.00
N/AN/AN/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GBS Inc. stock logo
GBS
GBS
N/AN/AN/AN/A$0.44 per shareN/A
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
N/AN/AN/AN/A($0.62) per shareN/A
INVO Fertility, Inc stock logo
IVF
INVO Fertility
$6.53M0.20N/AN/A($89.58) per share-0.02
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$1.05M21.24N/AN/A($0.03) per share-26.90
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GBS Inc. stock logo
GBS
GBS
-$8.31M-$0.56N/AN/AN/AN/A-85.64%-54.42%N/A
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
-$380KN/A0.00N/AN/AN/A-2.38%N/A
INVO Fertility, Inc stock logo
IVF
INVO Fertility
-$9.10M-$102.18N/AN/A-377.73%N/A-88.18%N/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
-$10.95M-$0.42N/AN/A-902.82%-4,813.07%-281.78%8/12/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
GBS Inc. stock logo
GBS
GBS
N/AN/AN/AN/AN/A
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
N/AN/AN/AN/AN/A
INVO Fertility, Inc stock logo
IVF
INVO Fertility
N/AN/AN/AN/AN/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GBS Inc. stock logo
GBS
GBS
N/A
2.33
2.33
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
N/A
0.17
0.61
INVO Fertility, Inc stock logo
IVF
INVO Fertility
N/A
0.08
0.07
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.02
0.42
0.47

Institutional Ownership

CompanyInstitutional Ownership
GBS Inc. stock logo
GBS
GBS
2.79%
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
89.71%
INVO Fertility, Inc stock logo
IVF
INVO Fertility
12.02%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
24.55%

Insider Ownership

CompanyInsider Ownership
GBS Inc. stock logo
GBS
GBS
0.27%
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
21.90%
INVO Fertility, Inc stock logo
IVF
INVO Fertility
0.57%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
10.84%
CompanyEmployeesShares OutstandingFree FloatOptionable
GBS Inc. stock logo
GBS
GBS
714.89 million14.85 millionNot Optionable
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
411.21 million8.76 millionNot Optionable
INVO Fertility, Inc stock logo
IVF
INVO Fertility
25720,000716,000No Data
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
2027.54 million19.06 millionNot Optionable

Recent News About These Companies

PetVivo Holdings Inc. to Trade on OTCQX Best Market
PetVivo (NASDAQ:PETV) Shares Up 0.6% - Here's What Happened
PetVivo Reports Fiscal 2025 Results - Seeking Alpha
PetVivo Reports Fiscal 2025 Results - Morningstar
PetVivo Reports Fiscal 2025 Results
PetVivo Holdings Inc (PETV)

New MarketBeat Followers Over Time

Media Sentiment Over Time

GBS stock logo

GBS NYSE:GBS

$1.58 +0.03 (+1.94%)
As of 07/31/2025

GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Health Sciences Acquisitions Co. 2 stock logo

Health Sciences Acquisitions Co. 2 NASDAQ:HSAQ

$3.12 -0.04 (-1.27%)
As of 07/30/2025

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.

INVO Fertility stock logo

INVO Fertility NASDAQ:IVF

$1.84 +0.02 (+1.10%)
As of 08/1/2025 04:00 PM Eastern

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

PetVivo stock logo

PetVivo NASDAQ:PETV

$0.81 +0.01 (+0.88%)
As of 08/1/2025 03:38 PM Eastern

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.